Cell-Dyn
Payments companies reported to CMS as associated with Cell-Dyn. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cell-Dyn, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cell-Dyn
These are the largest totals companies reported as associated with Cell-Dyn. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kun Ru | Pittsbrugh, PA | Anatomic Pathology & Clinical Pathology | $2,317.95 |
| Rajesh Sharma | Westminster, CO | Interventional Cardiology | $47.33 |
| Nicole Mccommon | Plain Dealing, LA | Family Medicine | $24.06 |
| Kayci Wilson | Vivian, LA | Family | $24.05 |
| Sherri Mcdonald | Charleston, MO | Adult Health (Nurse Practitioner) | $23.59 |
| Karen Tracy | Cape Girardeau, MO | Family | $23.59 |
| Sarah Goodman | Cape Girardeau, MO | Internal Medicine | $23.59 |
| Khalil Kaid | Maplewood, NJ | Cardiovascular Disease | $22.00 |
| Michael Bagwell | Senatobia, MS | Family Medicine | $19.23 |
| Alexandra Banker | Hernando, MS | Family | $19.22 |
Prescribed Cell-Dyn?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.